<- Go Home
SofWave Medical Ltd.
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and subsequent revitalization for regenerated skin under the SUPERB brand; and non-invasive muscle toning technology under the Pure Impact VIP brand. It serves plastic surgeons, dermatologists, and other physicians who perform aesthetic treatments on patients. It also provides technical and clinical product support services. The company was incorporated in 2015 and is based in Yokneam Illit, Israel.
Market Cap
ILS 536.6M
Volume
35.3K
Cash and Equivalents
ILS 34.8M
EBITDA
ILS 7.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
ILS 66.0M
Profit Margin
75.27%
52 Week High
ILS 15.78
52 Week Low
ILS 5.43
Dividend
N/A
Price / Book Value
16.60
Price / Earnings
106.11
Price / Tangible Book Value
16.60
Enterprise Value
ILS 503.0M
Enterprise Value / EBITDA
57.97
Operating Income
ILS 6.9M
Return on Equity
19.17%
Return on Assets
8.69
Cash and Short Term Investments
ILS 34.8M
Debt
ILS 1.1M
Equity
ILS 32.7M
Revenue
ILS 87.6M
Unlevered FCF
ILS 13.3M
Sector
Health Care Equipment and Supplies
Category
N/A